Subscribe

BIS2022 – Multi-Omics: The Future of Molecular Biology

BIS, BIS2022, Big Ideas Summit, Genomics,Multi-omics, Simon Barnett, Big Ideas
 

Leveraging the genome, transcriptome, proteome, and other ‘omics, scientists are likely to translate groundbreaking discoveries into clinical solutions. New analytics and software tools, especially those focused on high-throughput proteomics, should allow scientists to unlock the codes to life, disease, and health.

Originally aired on January 25, Big Ideas Summit 2022 features in-depth presentations from ARK’s research team and seeks to educate attendees on the impact of breakthrough technologies and the investment opportunities they could create.

Change appears to happen slowly and then all at once. Over time, innovation should displace industry incumbents, increase efficiencies, and gain majority market share. With the right understanding of disruptive innovation and a long-term time horizon, we believe investors will capture exponential growth opportunities, which deserve a strategic allocation in their portfolios. For this reason, ARK focuses on opportunities likely to scale as technologies converge, transforming entire industries.

To enlighten investors on the impact of breakthrough technologies we began publishing Big Ideas in 2017. This annual research report seeks to highlight our most provocative research conclusions for the coming year. We hope you enjoy our Big Ideas for 2022.

You are leaving ark-invest.com
By clicking below you acknowledge that you are navigating away from ark-invest.com and will be connected to ark-funds.com ARK Investment Management LLC manages both web domains. Please take note of ARK’s privacy policy, terms of use, and disclosures that may vary between sites.